Thirteen years of an international external quality assessment scheme for genotyping: Results and recommendations

Clinical Chemistry

Volumn 62, Issue 8, 2016, Pages 1084-1095

  Haselmann, Verena ^a   Geilenkeuser, Wolf J ^b   Helfert, Simona ^a   Eichner, Romy ^a   Hetjens, Svetlana ^a   Neumaier, Michael ^a   Ahmad Nejad, Parviz ^c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Reference Institute for Bioanalytics   (Germany)

^c UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; DNA;

ANALYTICAL ERROR; ARTICLE; ASSAY; EXTERNAL QUALITY ASSESSMENT; GENETIC SCREENING; GENOTYPE; HUMAN; LABORATORY; MAJOR CLINICAL STUDY; QUALITY CONTROL; GENETICS; HEALTH CARE QUALITY; STANDARDS;

DNA; GENETIC TESTING; GENOTYPE; HUMANS; QUALITY ASSURANCE, HEALTH CARE;

EID: 84979971884     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2016.254482     Document Type: Article

References (39)

1. Miller WG, Jones GR, Horowitz GL, Weykamp C. Proficiency testing/external quality assessment: current challenges and future directions. Clin Chem 2011;57: 1670-80.
2. CLSI. Molecular diagnostics methods for genetic diseases; approved guideline. Wayne (PA); CLSI; 2006. CLSI document MM01-A2.
3. Keathley J. QMS: a model for laboratory services gp26-a4. Lab Med 2012;43:26-8.
4. Ahmad-Nejad P, Dorn-Beineke A, Pfeiffer U, Brade J, Geilenkeuser WJ, Ramsden S, et al. Methodologic European external quality assurance for DNA sequencing: the EQUALseq program. Clin Chem 2006;52:716-27.
5. Dorn-Beineke A, Ahmad-Nejad P, Pfeiffer U, Ramsden S, Pazzagli M, Neumaier M. Improvement of technical and analytical performance in DNA sequencing by external quality assessment-based molecular training. Clin Chem 2006;52:2072-8.
6. Neumaier M, Braun A, Gessner R, Funke H. Experiences with external quality assessment (EQA) in molecular diagnostics in clinical laboratories in Germany. Working group of the German Societies for Clinical Chemistry (DGKC) and Laboratory Medicine (DGLM). Clin Chem Lab Med 2000;38:161-3.
7. Neumaier M, Braun A, Wagener C. Fundamentals of quality assessment of molecular amplification methods in clinical diagnostics. International Federation of Clinical Chemistry Scientific Division Committee on Molecular Biology Techniques. Clin Chem 1998;44:12-26.
8. International Organization for Standardization (ISO). Medical laboratories-particular requirements for quality and competence. Geneva: ISO; 2007. Document No. ISO 15189:2007.
9. International Organization for Standardization (ISO). General requirements for the competence of testing and calibration laboratories. Geneva: ISO; 2005. Document No. ISO/IEC 17025:2005.
10. Organisation for Economic Co-operation and Development: OECD guidelines for quality assurance in molecular genetic testing 2007. https://www.oecd. org/sti/biotech/38839788.pdf (Accessed June 2016).
11. La la loi hôpital, patients, santé et terrotoires (hpts). 2011. http://www.Sante.Gouv.Fr/la-loi-hopital-patientssante-et-territoires.html (Accessed January 2016).
12. Bundesministerium für gesundheit. Gendiagnostikgesetz. 2014. http://www.bmg.bund.de/glossarbegriffe/g/gendiagnostikgesetz.html (Accessed June 2016).
13. Mattocks CJ, Morris MA, Matthijs G, Swinnen E, Corveleyn A, Dequeker E, et al. A standardized framework for the validation and verification of clinical molecular genetic tests. Eur J Hum Genet 2010;18:1276-88.
14. McGuire AL, Fisher R, Cusenza P, Hudson K, Rothstein MA, McGraw D, et al. Confidentiality, privacy, and security of genetic and genomic test information in electronic health records: points to consider. Genet Med 2008;10:495-9.
15. Berwouts S, Girodon E, Schwarz M, Stuhrmann M, Morris MA, Dequeker E. Improvement of interpretation in cystic fibrosis clinical laboratory reports: longitudinal analysis of external quality assessment data. Eur JHum Genet 2012;20:1209-15.
16. Hastings RJ, Howell RT. The importance and value of EQA for diagnostic genetic laboratories. J Community Genet 2010;1:11-7.
17. Stenhouse SA, Middleton-Price H. Quality assurance in molecular diagnosis : the UK experience. Methods Mol Med 1996;5:341-52.
18. Eurogentest. Molecular genetic testing-external quality assessment scheme provision. 2007. http://www.Eurogentest.Org/index.Php?Id=706 (Accessed January 2016).
19. IFCC-molecular genetic testing-external quality assessment schemes. 2015. http://www.Ifcc.Org/media/285200/mdxeqa%20list%20v1%20220115-genotyping.Pdf (Accessed January 2016).
20. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
21. Didenko VV. DNA probes using fluorescence resonance energy transfer (FRET): designs and applications. Bio-Techniques 2001;31:1106-16, 18, 20-1.
22. Emig M, Saussele S, Wittor H, Weisser A, Reiter A, Willer A, et al. Accurate and rapid analysis of residual disease in patients with cml using specific fluorescent hybridization probes for real time quantitative RT-PCR. Leukemia 1999;13:1825-32.
23. Heid CA, Stevens J, Livak KJ, Williams PM. Real time quantitative PCR. Genome Res 1996;6:986-94.
24. Koch WH. Technology platforms for pharmacogenomic diagnostic assays. Nat Rev Drug Discov 2004;3:749-61.
25. Alkan C, Coe BP, Eichler EE.Genomestructural variation discovery and genotyping. Nat Rev Genet 2011;12: 363-76.
26. Buh Gasparic M, Tengs T, La Paz JL, Holst-Jensen A, Pla M, Esteve T, et al. Comparison of nine different realtime PCR chemistries for qualitative and quantitative applications in GMO detection. Anal Bioanal Chem 2010;396:2023-9.
27. Navarro E, Serrano-Heras G, Castano MJ, Solera J. Realtime PCR detection chemistry. Clin Chim Acta 2015; 439:231-50.
28. Bersaglieri T, Sabeti PC, Patterson N, Vanderploeg T, Schaffner SF, Drake JA, et al. Genetic signatures of strong recent positive selection at the lactase gene. Am J Hum Genet 2004;74:1111-20.
29. Enattah NS, Sahi T, Savilahti E, Terwilliger JD, Peltonen L, Jarvela I. Identification of a variant associated with adult-type hypolactasia. Nat Genet 2002;30:233-7.
30. The human cytochrome p450 (CYP) allele nomenclature database. http://www.Cypalleles.Ki.Se/.
31. Sim SC, Ingelman-Sundberg M. The human cytochrome p450 (CYP) allele nomenclature website: a peer-reviewed database of CYP variants and their associated effects. Hum Genomics 2010;4:278-81.
32. Sim SC, Ingelman-Sundberg M. Update on allele nomenclature for human cytochromes p450 and the human cytochrome p450 allele (CYP-allele) nomenclature database. Methods Mol Biol 2013;987:251-9.
33. Porto G, Brissot P, Swinkels DW, Zoller H, Kamarainen O, Patton S, et al.EMQNbest practice guidelines for the molecular genetic diagnosis of hereditary hemochromatosis (HH). Eur J Hum Genet 2015.
34. Cassiman JJ. Research network: Eurogentest-a European network of excellence aimed at harmonizing genetic testing services. Eur J Hum Genet 2005;13: 1103-5.
35. US Food and Drug Administration. Table of pharmacogenomic biomarkers in drug labeling. http://www.fda.gov/drugs/scienceresearch/researchareas/pharmacogenetics/ucm083378.Htm (accessed February 2016).
36. Dequeker E, Ramsden S, Grody WW, Stenzel TT, Barton DE. Quality control in molecular genetic testing. Nat Rev Genet 2001;2:717-23.
37. Weiskirchen R, Tag CG, Mengsteab S, Gressner AM, Ingram CJ, Swallow DM. Pitfalls in Lightcycler diagnosis of the single-nucleotide polymorphism 13.9 kb upstream of the lactase gene that is associated with adult-type hypolactasia. Clin Chim Acta 2007; 384:93-8.
38. Chen B, Gagnon M, Shahangian S, Anderson NL, Howerton DA, Boone JD. Good laboratory practices for molecular genetic testing for heritable diseases and conditions. MMWR Recomm Rep 2009;58:1-37; quiz CE-1-4.
39. Human Genome Variation Society. http://www.hgvs.org/(Accessed June 2016).